ORDER

Buy Retatrutide 20mg | Peptide Triple Agonist GLP-1/GIP/Glucagon

Note5.00out of 5 based on1customer rating
(1(Customer review)

129,90 

Retatrutide 20mg (LY3437943) — high-dose format, intensive protocols. Triple GLP-1/GIP/Glucagon agonist, weight reduction up to -24% in Phase 2. HPLC purity ≥99% Janoshik. COA per batch. Lyophilized -20°C. Shipping to Europe 48-72h.

QuantityPrice / unitYou save
1129,90 
2116,90 -13,00 / u.
3–4103,90 -26,00 / u.
5–994,90 -35,00 / u.
10+81,90 -48,00 / u.

Le Retatrutide 20mg(LY3437943, GLP-3) is the high-dose form of the reference triagonist peptide in metabolic research. By simultaneously activating the receptorsGLP-1, GIP et glucagonIt is the most powerful agent currently available in its class for studying the mechanisms of weight loss and metabolic regulation.

Results of clinical trials

The Phase 2 clinical trial data published in theNew England Journal of Medicine(Jastreboff et al., 2023) show aaverage reduction in body weight of 17.5% to 24.2%based on the dosage over 48 weeks — significantly outperforming Semaglutide (~15%) and Tirzepatide (~22%) at equivalent doses. Retatrutide is currently in Phase 3 clinical trials.

Triple agonist mechanism

The mechanism of action is based on three axes: (1) agonismGLP-1reduces appetite via hypothalamic centers and slows gastric emptying; (2) agonismGIPimproves insulin sensitivity and potentiates glucose-dependent insulin secretion; (3) agonismglucagonIt increases thermogenesis, basal energy expenditure, and stimulates hepatic lipolysis. This triple convergence explains the superiority observed compared to mono- and dual-agonists.

20mg format — for intensive protocols

The 20mg format is suitable for advanced research protocols requiring higher doses or longer durations. It allows for the high doses (8mg-12mg/week) used in Phase 2 clinical trials to be achieved with a reduced number of vials. Recommended for experienced researchers who have already used the 10mg format.

Technical specifications

  • HPLC Purity≥99%certified by Janoshik Analytical
  • Batch Certificate of Analysis (COA) — full traceability
  • Freeze-dried form — stability 24 months to-20°C
  • Recommended reconstitution: 2 mL of bacteriostatic water
  • Peptide sequence: acylated analog of GIP with structural modifications GLP-1/glucagon

Storage and handling

Unreconstituted lyophilized solution: stable for 24 months at -20°C. Reconstituted solution: stable for 4 weeks at +4°C, protected from light. Handle under aseptic conditions. Avoid freezing the reconstituted solution. This product is intended for scientific research use only.

Shipping to Europe

Discreet shipping within 48-72 hours to France, Belgium, Luxembourg, Germany, Spain, Italy, the Netherlands, Poland, and Portugal. Secure packaging, temperature controlled. SEPA transfer or card accepted.

Weight 0.5 kg

1 review forBuy Retatrutide 20mg | Peptide Triple Agonist GLP-1/GIP/Glucagon

  1. Note5out of 5

    Lobna JARJIR

Add a Review

Your email address will not be published. Required fields are indicated with an asterisk (*).*

FRENDEITES
Back to top